CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED
Get an alert when CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£154k
-18.9% vs 2024
Net assets
£229k
-56.7% vs 2024
Employees
13
+8.3% vs 2024
Profit before tax
-£3.6m
-52.8% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
In view of the above, the directors have concluded that a material uncertainty exists that may cast significant doubt upon the group's ability to continue as a going concern. ... The group therefore continues to adopt the going concern basis in preparing its consolidated financial statements.
-
Going-concern uncertainty disclosed
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | -£3,066,000 | -£3,514,800 | -14.6% | |
| Profit before tax | -£2,345,000 | -£3,583,100 | -52.8% | |
| Net profit | -£2,347,000 | -£3,584,600 | -52.7% | |
| Cash | £189,800 | £153,900 | -18.9% | |
| Total assets less current liabilities | £4,646,600 | £4,812,800 | +3.6% | |
| Net assets | £528,000 | £228,700 | -56.7% | |
| Equity | £528,000 | £228,700 | -56.7% | |
| Average employees | 12 | 13 | +8.3% | |
| Wages | £1,373,600 | £1,516,500 | +10.4% | |
| Directors' remuneration | £508,100 | £491,700 | -3.2% | |
| Highest paid director | £288,800 | £280,500 | -2.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Return on capital employed | -66.0% | -73.0% | |
| Gearing (liabilities / total assets) | 90.4% | 95.5% | |
| Current ratio | 0.65x | 1.86x | |
| Interest cover | — | -51.46x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED 2014-11-26 → present
- CLINETIK LIMITED 2014-09-26 → 2014-11-26
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Frazier & Deeter (UK Audit) LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“In view of the above, the directors have concluded that a material uncertainty exists that may cast significant doubt upon the group's ability to continue as a going concern. ... The group therefore continues to adopt the going concern basis in preparing its consolidated financial statements.”
Group structure
- CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED · parent
- Cambridge Medical Technologies, LLC 100%
- Clinitech, LLC 100%
- CMT Japan Inc 100%
Significant events
- “Since the end of the year, the company has received £1,624,500 of new equity investment, and a further £600,000 is under contract.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COOKE, James | Director | 2016-05-23 | Jan 1966 | British |
| JACHMANN, Emil | Director | 2014-09-26 | Mar 1947 | American |
| LACEY-SOLYMAR, Michael Julian | Director | 2015-10-16 | Feb 1963 | British |
| PRESS, Richard | Director | 2025-09-17 | Jan 1939 | American |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORNELIUS, James | Director | 2017-02-02 | 2025-11-11 |
| DIBDEN, Lindsay George | Director | 2017-02-02 | 2019-02-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Emil Frederick Jachmann | Individual | Shares 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 106 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-30 | AA | accounts | Accounts with accounts type group | |
| 2026-09-25 | SH01 | capital | Capital allotment shares | |
| 2026-09-25 | SH01 | capital | Capital allotment shares | |
| 2026-08-06 | RP01SH01 | miscellaneous | Legacy | |
| 2026-08-03 | SH01 | capital | Capital allotment shares | |
| 2026-03-23 | SH01 | capital | Capital allotment shares | |
| 2026-03-23 | SH01 | capital | Capital allotment shares | |
| 2026-03-23 | SH01 | capital | Capital allotment shares | |
| 2025-11-23 | SH01 | capital | Capital allotment shares | |
| 2025-11-14 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-22 | SH01 | capital | Capital allotment shares | |
| 2025-10-21 | SH01 | capital | Capital allotment shares | |
| 2025-09-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-09-26 | AA | accounts | Accounts with accounts type group | |
| 2025-09-25 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-06 | SH01 | capital | Capital allotment shares | |
| 2025-09-06 | SH01 | capital | Capital allotment shares | |
| 2025-08-03 | SH01 | capital | Capital allotment shares | |
| 2025-08-03 | SH01 | capital | Capital allotment shares | |
| 2025-05-27 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 12
- Capital events
- 14
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.